Posted by Michael Wonder on 14 Dec 2020
U.S. Government exercises first option for additional 100 million doses of Moderna’s COVID-19 vaccine candidate
11 December 2020 - Additional doses ordered today will be delivered in Q2 2021.
Moderna today announced that the U.S. Government has exercised its option to purchase an additional 100 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 200 million doses.
